Our people Our people Ambition. Passion. Integrity. Commitment. Empathy. Individuality. We expect these qualities at all levels.
Our Work with the Gates Foundation | COVID-19 | Boehringer Ingelheim US Our Work with the Gates Foundation | COVID-19 | Boehringer Ingelheim US With global life science companies, we are joining the COVID-19 Therapeutics Accelerator of the Bill & Melinda Gates Foundation to fight the pandemic.
What to Expect from Your Vaccine | Boehringer Ingelheim US What to Expect from Your Vaccine | Boehringer Ingelheim US Read more on how horse owners are encouraged to schedule a wellness exam with their veterinarians, including annual equine vaccinations.
About Us About Us Click here to discover more about Boehringer Ingelheim and our headquarters and largest U.S subsidiary in Connecticut.
Contact Our Team | Human Health | Boehringer Ingelheim US Contact Our Team | Human Health | Boehringer Ingelheim US Find all our contact information here as well as the latest updates on where you can meet our partnering teams virtually or in person.
Life Forward Life Forward In everything we do we can shape and influence the future for the better: Learn more about “Life forward” and how our innovations improve lives.
Celebrating Innovation | Partnering Celebrating Innovation | Partnering BI’s Innovation Prize was established in Boston in 2015 to recognize the challenge and dedication of entrepreneurs in advancing new ideas & science.
A Holistic Approach to Cardio-Renal-Metabolic Care | Boehringer Ingelheim US A Holistic Approach to Cardio-Renal-Metabolic Care | Boehringer Ingelheim US Our Blueprint for Constructing a Holistic Approach to Cardio-renal-metabolic Care
Global Careers Page | Boehringer Ingelheim Global Careers Page | Boehringer Ingelheim Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide.
Boehringer Ingelheim Presents First Head-to-Head Matched Population Comparison Boehringer Ingelheim Presents First Head-to-Head Matched Population Comparison Boehringer Ingelheim Presents First Head-to-Head Matched Population Comparison
Brigitte Fuhr Brigitte Fuhr Brigitte Fuhr, Head of Central Data Science, is working on a global program that will transform our ability to develop breakthrough treatments.
We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets. We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets. We’re investing $50 million in Puerto Rico. It will increase our ability to make products to protect pets.
About our Innovation Prize About our Innovation Prize Established in 2015 and jointly sponsored by BI and the BI Venture Fund, the prize allows recipients to focus on development of breakthrough medicines.
Our Respiratory Partnering Interests Our Respiratory Partnering Interests Our Respiratory Partnering Interests